TICKERNOMICS Sign up
Last Update: 2023-10-04 11:34:42
Intelligent Medicine Acquisition Corp. ( IQMD )
11.04USD
Sector:
Financial Services
Industry:
Shell Companies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
IQMD
9.52%
SPY
36.71%
IQMD
0.00%
SPY
70.96%
IQMD
0.00%
SPY
262.36%
IQMD
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
57.13
57.08
0.22
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
5.78
0.00
0.28
0.00
0.00
-4.94
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.69
-6.41
-7.06
0.00
Other Earnings and Cash Flow Stats:
Intelligent Medicine Acquisition Corp. ( IQMD ) Net Income TTM ($MM) is 4366146.04
Intelligent Medicine Acquisition Corp. ( IQMD ) Operating Income TTM ($MM) is 4366129.42
Intelligent Medicine Acquisition Corp. ( IQMD ) Owners' Earnings Annual ($MM) is 0.00
Intelligent Medicine Acquisition Corp. ( IQMD ) Current Price to Owners' Earnings ratio is 0.00
Intelligent Medicine Acquisition Corp. ( IQMD ) EBITDA TTM ($MM) is 4366129.42
Intelligent Medicine Acquisition Corp. ( IQMD ) EBITDA Margin is 0.00%
Capital Allocation:
Intelligent Medicine Acquisition Corp. ( IQMD ) has paid 0.00 dividends per share and bought back 20.7 million shares in the past 12 months
Intelligent Medicine Acquisition Corp. ( IQMD ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Intelligent Medicine Acquisition Corp. ( IQMD ) Interest-bearing Debt ($MM) as of last quarter is 0
Intelligent Medicine Acquisition Corp. ( IQMD ) Annual Working Capital Investments ($MM) are 0
Intelligent Medicine Acquisition Corp. ( IQMD ) Book Value ($MM) as of last quarter is 202
Intelligent Medicine Acquisition Corp. ( IQMD ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Intelligent Medicine Acquisition Corp. ( IQMD ) has 0 million in cash on hand as of last quarter
Intelligent Medicine Acquisition Corp. ( IQMD ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Intelligent Medicine Acquisition Corp. ( IQMD ) has 5 common shares outstanding as of last quarter
Intelligent Medicine Acquisition Corp. ( IQMD ) has 0 million USD of preferred stock value
Academic Scores:
Intelligent Medicine Acquisition Corp. ( IQMD ) Altman Z-Score is 2.69 as of last quarter
Intelligent Medicine Acquisition Corp. ( IQMD ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Intelligent Medicine Acquisition Corp. ( IQMD ) largest shareholder is Sunrise Partners LLC owning 0 shares at 0.00 ($MM) value
(an insider) shares of Intelligent Medicine Acquisition Corp. ( IQMD ) for the amount of $ on
0.00% of Intelligent Medicine Acquisition Corp. ( IQMD ) is held by insiders, and 2582.69% is held by institutions
Intelligent Medicine Acquisition Corp. ( IQMD ) went public on 2021-12-27
Other Intelligent Medicine Acquisition Corp. ( IQMD ) financial metrics:
FCF:-186211.68
Unlevered Free Cash Flow:0.00
EPS:2.19
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:5.60
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Intelligent Medicine Acquisition Corp. ( IQMD ) :
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.